Literature DB >> 17558359

Continuous scale physical functional performance test: appropriateness for middle-aged adults with and without Parkinson's disease.

Thomas M Hearty1, Margaret L Schenkman, Wendy M Kohrt, M Elaine Cress.   

Abstract

PURPOSE: Functional measures are needed that are applicable to middle-aged adults with neurological disorders who are on the threshold of disability. One potential measure is the Continuous Scale Physical Functional Performance Test (CS-PFP), which has been normalized and validated to older adults but performance is unknown for adults younger than the age of 65 years with and without neurological disorders. The purposes of this investigation were (1) to compare scores on the CS-PFP of nondisabled adults in three age groups from 35 to 64 years with two groups of individuals older than the age of 65; (2) to determine whether there is a ceiling effect for nondisabled middle-aged adults; and (3) to determine whether performance of individuals in early stages of Parkinson's disease (PD) age 45 to 64 years differ significantly from performance of similarly aged nondisabled adults.
METHODS: Data were obtained from three samples: (1) 37 adults with PD (45-54 and 55-64 years; 57% female), (2) 70 nondisabled adults (35-44, 45-54, and 55-64 years; 69% female); (3) 72 nondisabled older adults (65-74 and 75-85 years; 79% female). The CS-PFP was administered in a single test session for each subject. Analysis of variance was performed for group differences with adjustment of sex as a covariate followed by a Student-Newman-Keuls post hoc analysis.
RESULTS: For nondisabled individuals, the CS-PFP total and domain scores were significantly lower in the oldest group (75-85 years) compared to all other age groups and significantly higher in the younger two groups (35-44 and 45-54 years) compared to the older groups. There was no ceiling effect for any domain score or total score for the adults younger than 65 years. For individuals with PD, both age groups had significantly lower scores on the CS-PFP than did the nondisabled counterparts.
CONCLUSIONS: Results from the nondisabled middle-aged individuals provide comparison data to be used clinically or in investigations of middle-aged adults with neurological dysfunction. Comparison of middle-aged individuals with PD to middle-aged nondisabled adults illustrates the true extent of functional difficulty experienced by individuals with PD and demonstrates the importance of using age appropriate comparison data. The CS-PFP is particularly applicable to middle-aged adults with compromised functional performance for their age but is too high to be effectively quantified with other assessment measures.

Entities:  

Mesh:

Year:  2007        PMID: 17558359     DOI: 10.1097/NPT.0b013e3180676afa

Source DB:  PubMed          Journal:  J Neurol Phys Ther        ISSN: 1557-0576            Impact factor:   3.649


  9 in total

1.  A combined aerobic and resistance exercise program improves physical functional performance in patients with heart failure: a pilot study.

Authors:  Rebecca A Gary; M Elaine Cress; Melinda K Higgins; Andrew L Smith; Sandra B Dunbar
Journal:  J Cardiovasc Nurs       Date:  2012 Sep-Oct       Impact factor: 2.083

2.  Reply: Is an Earlier and More Intensive Physical Therapy Program Better?

Authors:  Amy Nordon-Craft; Dan Malone; Margaret Schenkman; Marc Moss
Journal:  Am J Respir Crit Care Med       Date:  2016-10-15       Impact factor: 21.405

3.  CONCURRENT VALIDITY OF THE CONTINUOUS SCALE-PHYSICAL FUNCTIONAL PEFORMANCE-10 (CS-PFP-10) TEST IN TRANSFEMORAL AMPUTEES.

Authors:  M Jason Highsmith; Jason T Kahle; Rebecca M Miro; M Elaine Cress; William S Quillen; Stephanie L Carey; Rajiv V Dubey; Larry J Mengelkoch
Journal:  Technol Innov       Date:  2016-09-01

4.  Profile of functional limitations and task performance among people with early- and middle-stage Parkinson disease.

Authors:  Margaret Schenkman; Terry Ellis; Cory Christiansen; Anna E Barón; Linda Tickle-Degnen; Deborah A Hall; Robert Wagenaar
Journal:  Phys Ther       Date:  2011-07-21

5.  Effects of testosterone and progressive resistance exercise in healthy, highly functioning older men with low-normal testosterone levels.

Authors:  Kerry L Hildreth; Daniel W Barry; Kerrie L Moreau; Joseph Vande Griend; Randall B Meacham; Tammie Nakamura; Pamela Wolfe; Wendy M Kohrt; J Mark Ruscin; John Kittelson; M Elaine Cress; Robert Ballard; Robert S Schwartz
Journal:  J Clin Endocrinol Metab       Date:  2013-03-26       Impact factor: 5.958

6.  Determinants of objectively measured physical functional performance in early to mid-stage Parkinson disease.

Authors:  Benzi M Kluger; R Preston Brown; Shanae Aerts; Margaret Schenkman
Journal:  PM R       Date:  2014-05-28       Impact factor: 2.298

7.  The Relationship Between Mobility Dysfunction Staging and Global Cognitive Performance.

Authors:  Magdalena I Tolea; James E Galvin
Journal:  Alzheimer Dis Assoc Disord       Date:  2016 Jul-Sep       Impact factor: 2.703

Review 8.  Understanding and optimizing health-related quality of life and physical functional capacity in idiopathic pulmonary fibrosis.

Authors:  Amy L Olson; Kevin K Brown; Jeffrey J Swigris
Journal:  Patient Relat Outcome Meas       Date:  2016-05-17

9.  What Determines Spontaneous Physical Activity in Patients with Parkinson's Disease?

Authors:  Agnieszka Gorzkowska; Joanna Cholewa; Andrzej Małecki; Aleksandra Klimkowicz-Mrowiec; Jarosław Cholewa
Journal:  J Clin Med       Date:  2020-05-01       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.